Welcome to our dedicated page for Asgn SEC filings (Ticker: ASGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ASGN Incorporated (NYSE: ASGN) files periodic and current reports with the U.S. Securities and Exchange Commission that provide detailed information about its operations as a provider of IT services and solutions across the commercial and government sectors. On this page, you can access ASGN’s SEC filings alongside AI-powered tools that help explain key disclosures.
ASGN’s recent Form 8-K filings illustrate several types of information investors can follow. Some 8-Ks report quarterly financial results, where the company discusses revenues by Commercial and Federal Government segments, IT consulting versus assignment revenues, and revenue categorizations by industry and customer type. Other 8-Ks describe amendments to the company’s bylaws, including procedures for stockholder nominations, proposals, special meetings, and indemnification provisions, giving insight into ASGN’s governance framework.
Additional 8-K filings address financing arrangements, such as amendments to the company’s credit agreement that add incremental term loan capacity and describe interest terms, covenants, and intended uses of proceeds, including organic investments, acquisition capacity, and share repurchases. These filings help readers understand ASGN’s capital structure and liquidity planning.
Through this filings page, users can review ASGN’s current reports and, where available, annual reports on Form 10-K and quarterly reports on Form 10-Q. AI-generated summaries highlight important sections, such as segment discussions, risk factors referenced in other filings, and descriptions of governance or financing changes. Filings related to executive and director matters, such as bylaw amendments and indemnification updates, can also be examined to understand how ASGN manages board and stockholder processes.
For those analyzing ASGN’s regulatory history, this page centralizes access to its SEC documents and provides tools to interpret complex legal and financial language. This can help users quickly locate information about segment reporting, governance changes, and material agreements disclosed in ASGN’s filings.
ASGN Inc. director Brian J. Callaghan reported receiving a new equity award in the form of common stock. On 01/02/2026, he acquired 4,500 shares of ASGN common stock at a price of $46.66 per share. The filing explains that this grant of restricted stock units vests 50% on the grant date and the remaining 50% on the one-year anniversary of the grant date, subject to continued service to the company.
Following this transaction, Callaghan beneficially owns 7,698 shares directly and an additional 323,829 shares indirectly through a trust. This filing reflects director equity compensation and updates his reported ownership in ASGN.
ASGN Inc. — Schedule 13G/A (Amendment No. 7): FMR LLC and Abigail P. Johnson reported beneficial ownership of ASGN common stock. As of 09/30/2025, FMR LLC reported 1,791,471.35 shares, representing 4.1% of the class. FMR reported sole voting power over 1,782,582.00 shares and sole dispositive power over 1,791,471.35 shares, with no shared voting or dispositive power.
Abigail P. Johnson reported sole dispositive power over 1,791,471.35 shares and no voting power. The filing certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. One or more other persons may have rights to dividends or sale proceeds, and no single such interest exceeds five percent.
ASGN Incorporated reported Q3 2025 results with revenues of $1,011.4 million versus $1,031.0 million a year ago, and diluted EPS of $0.87 versus $1.06. Net income was $38.1 million. Gross margin improved 30 bps to 29.4% as mix shifted toward consulting. Operating income was $67.9 million and interest expense rose to $17.4 million.
By segment, Commercial consulting rose 17.5% to $334.9 million, while Assignment declined 13.2% to $376.4 million. Federal Government revenues decreased 3.9% to $300.1 million. Year-to-date operating cash flow was $225.6 million. ASGN closed the $340.0 million TopBloc acquisition (90% cash, 10% equity), ending with long‑term debt of $1,165.7 million and approximately $460.0 million available on its revolver. Q3 share repurchases totaled 914,914 shares at an average price of $51.36. Shares outstanding were 43.1 million at September 30, 2025 and 42.7 million at October 24, 2025.
ASGN Incorporated announced its financial results for the third quarter of 2025 and furnished a press release as Exhibit 99.1. Management will host an earnings conference call at 4:30 p.m. Eastern time on October 22, 2025, with a live audio broadcast and supplemental presentation available through the Investor Relations section of the company’s website.
The information provided, including Exhibit 99.1, is being furnished rather than filed under the Exchange Act and is not subject to Section 18 liabilities, nor incorporated by reference into other filings unless expressly stated.
ASGN Incorporated's Board adopted an amended and restated set of bylaws. The changes modernize procedural and disclosure rules for stockholder nominations and proposals, require nominees to complete a background and disclosure questionnaire, and add mechanics for calling special meetings or acting by written consent. The amendments also update notice procedures for special Board meetings, clarify resignation procedures for directors and officers, revise stock transfer and record date processes, and modify indemnification provisions for directors and officers. For the 2026 annual meeting, business proposals must be delivered to the Secretary no earlier than the close of business on February 12, 2026 and no later than the close of business on March 14, 2026.
ASGN Inc. (NYSE: ASGN) executed a Second Amendment to its Third Amended and Restated Credit Agreement on 31 Jul 2025, immediately drawing an $100 million Incremental Term A loan.
The loan bears either (i) base rate +0.50-1.50 ppt or (ii) 1/3/6-mo. SOFR +1.50-2.50 ppt, with the spread determined by ASGN’s consolidated secured leverage ratio. Quarterly amortization is $625k for the first four quarters and $1.25 m thereafter; final maturity is 14 Feb 2028. A covenant caps secured leverage at 3.75×. Obligations are secured by substantially all assets and guaranteed by material U.S. subsidiaries, mirroring the existing facility’s terms.
The incremental debt raises liquidity, frees capacity under the $500 m revolver due 2028, and may fund organic growth, M&A and share repurchases. Fees and customary covenants/events of default remain unchanged.